The market for Cell Expansion was valued at US$ 13,066.2 million in 2021, and it is anticipated to increase to US$ 39,121.1 million by 2027, with a CAGR of 11.9% during 2022 and 2027.
The process of creating daughter cells from a single cell is known as cell expansion. In order for a cell to expand, new cell wall material must be produced, and the wall must be gradually loosened to allow for stretching and area growth. Key players in this process are cell-wall-associated proteins from the so-called expansion family. It is used in cell microbiology research, medication development, and drug screening. Today, cell expansion is often used to enhance transplantation and the treatment of illnesses including diabetes and rheumatoid arthritis.
The primary driver of the worldwide cell expansion market's expansion is the rise in the prevalence of chronic diseases like cancer, diabetes, and rheumatoid arthritis. The market is also being driven by an increase in government funding for cell-based research as well as a greater emphasis on R&D for cell-based therapeutics. Cell biology research ethics issues, a lack of qualified specialists, and the expensive cost of cell-based medicines could, nevertheless, restrain the market's rise. On the other hand, the market for cell expansion is presented with lucrative potential due to the development of opportunity in emerging economies and the increased focus on personalized treatment.
December 2, 2019: GE Healthcare Life Sciences releases software for cell therapy workflow --
GE Healthcare Life Sciences continues to build out its flexible solutions across the cell therapy workflow with the commercial availability of SpinOculation C-Pro Protocol Software. Part of the Sepax™ C-Pro Cell Processing System, the software closes and automates the cell transduction step. When used in combination with the Sepax C-Pro instrument and CT-60.1 single-use kit, the software enables users to choose the volume and cell concentration from initial cell preparation through transduction to final resuspension, without compromising cell viability and virus stability.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
Asia Pacific is anticipated to see the quickest growth throughout the projected period as a result of increased efforts made by various local pharmaceutical and biotechnology companies to develop and promote their cellular treatments.
In 2021, North America had the highest share of 43.1%. The significant market share of the sector is attributed to factors such as rising cancer incidence, rising government funding, increasing stem cell therapy research activities, growing public awareness of cutting-edge treatment options, rising geriatric population, and the significant presence of industry players in the area. The field will continue to hold the top spot over the coming years thanks to increased government funding initiatives that have accelerated the manufacturing of stem cells and the development of regenerative medicine and cellular therapy products. This further increases the demand for cell expansion platforms in this area.
The Cell Expansion Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Cell Expansion Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 11.9% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | GE Healthcare Life Sciences, Thermo Fisher Scientific, Xpand Biotechnology, BINKIT, AMMSTM, Lonza Group, Becton, Dickinson and Company, Xpand Biotechnology, BINKIT, Corning, Inc., Merck KGaA, Miltenyi Biotec, Terumo Bct, Inc., Sartorius AG, Takara Bio, Inc., Trinova Biochem GmbH, upcyte technologies GmbH |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 90 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Cell Expansion Market?
The Cell Expansion Market is growing at a CAGR of 11.9% over the next 5 years.
Who are the key players in Cell Expansion Market?
GE Healthcare Life Sciences, Thermo Fisher Scientific, Xpand Biotechnology, BINKIT, AMMSTM, Lonza Group, Becton, Dickinson and Company, Xpand Biotechnology, BINKIT, Corning, Inc., Merck KGaA, Miltenyi Biotec, Terumo Bct, Inc., Sartorius AG, Takara Bio, Inc., Trinova Biochem GmbH, upcyte technologies GmbH
What are the significant types of Cell Expansion Market?
Reagent, Media, Bioreactor
What are the major end-use applications of Cell Expansion Market?
Regenerative Medicine, Cell Banking, Cancer Research, Other
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.